Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prescribing Pattern and Safety Profile of Biological Agents for Psoriasis in Real-World Practice: A Four-Year Calabrian Pharmacovigilance Analysis.
De Sarro C, Bosco F, Gagliardi A, Guarnieri L, Ruga S, Fabiano A, Costantino L, Leo A, Palleria C, Verduci C, Rania V, Ashour M, Gallelli L, Citraro R, Sarro G. De Sarro C, et al. Pharmaceutics. 2024 Oct 14;16(10):1329. doi: 10.3390/pharmaceutics16101329. Pharmaceutics. 2024. PMID: 39458658 Free PMC article.
SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study.
Gonella LA, Moretti F, Capuano A, De Sarro C, Ferrara L, Geninatti E, Guarnieri G, Hysolakoj X, Lalli M, Leoni O, Mangano AMP, Marani Toro P, Mecchia V, Merlano MC, Palleria C, Potenza AM, Rossi P, Rossi M, Sanità F, Sapigni E, Scavone C, Sommaro C, Tuccori M, Zanoni G, Moretti U, VigiVax Working Group. Gonella LA, et al. Among authors: de sarro c. Vaccines (Basel). 2024 Sep 20;12(9):1076. doi: 10.3390/vaccines12091076. Vaccines (Basel). 2024. PMID: 39340106 Free PMC article.
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials.
Ahmadizar F, Luxi N, Raethke M, Schmikli S, Riefolo F, Saraswati PW, Bucsa C, Osman A, Liddiard M, Maques FB, Petrelli G, Sonderlichová S, Thurin NH, Villalobos F, Trifirò G, Sturkenboom M; ilmiovaccinoCOVID19 collaborating group. Ahmadizar F, et al. Drug Saf. 2023 Jun;46(6):575-585. doi: 10.1007/s40264-023-01304-5. Epub 2023 Apr 27. Drug Saf. 2023. PMID: 37103643 Free PMC article.
Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes.
Cassano V, Tallarico M, Armentaro G, De Sarro C, Iannone M, Leo A, Citraro R, Russo E, De Sarro G, Hribal ML, Sciacqua A. Cassano V, et al. Among authors: de sarro c. Int J Mol Sci. 2022 Dec 18;23(24):16160. doi: 10.3390/ijms232416160. Int J Mol Sci. 2022. PMID: 36555798 Free PMC article.
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study.
Tallarico M, Palleria C, Ruffolo L, Spagnuolo R, Naturale MD, De Francesco AE, De Sarro C, Romeo R, Citraro R, Doldo P, Abenavoli L, Gallelli L, Luzza F, Leo A, De Sarro G. Tallarico M, et al. Among authors: de sarro c. Pharmaceutics. 2022 Nov 13;14(11):2449. doi: 10.3390/pharmaceutics14112449. Pharmaceutics. 2022. PMID: 36432640 Free PMC article.
Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region.
Gagliardi A, Iaquinta FS, Grembiale RD, De Sarro C, Fabiano A, Fraija D, Palleria C, Romeo R, De Francesco AE, Naturale MD, Citraro R, Gallelli L, Leo A, De Sarro G. Gagliardi A, et al. Among authors: de sarro c. Pharmaceutics. 2022 Oct 28;14(11):2328. doi: 10.3390/pharmaceutics14112328. Pharmaceutics. 2022. PMID: 36365146 Free PMC article.
22 results